News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
639,004 Results
Type
Article (52179)
Company Profile (398)
Press Release (586427)
Multimedia
Podcasts (97)
Webinars (12)
Section
Business (167003)
Career Advice (3093)
Deals (30396)
Drug Delivery (105)
Drug Development (79971)
Employer Resources (176)
FDA (15259)
Job Trends (13394)
News (298502)
Policy (29207)
Tag
Academia (2843)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (91)
Alliances (44738)
ALS (99)
Alzheimer's disease (1450)
Antibody-drug conjugate (ADC) (151)
Approvals (15223)
Artificial intelligence (279)
Autoimmune disease (28)
Automation (15)
Bankruptcy (295)
Best Places to Work (11034)
BIOSECURE Act (22)
Biosimilars (102)
Biotechnology (305)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (303)
Cancer (2389)
Cardiovascular disease (194)
Career advice (2608)
Career pathing (33)
CAR-T (176)
Cell therapy (493)
Cervical cancer (22)
Clinical research (64791)
Collaboration (898)
Company closure (2)
Compensation (536)
Complete response letters (27)
COVID-19 (2632)
CRISPR (49)
C-suite (257)
Cystic fibrosis (109)
Data (2324)
Decentralized trials (2)
Denatured (29)
Depression (52)
Diabetes (285)
Diagnostics (5795)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (44)
Drug discovery (128)
Drug pricing (109)
Drug shortages (31)
Duchenne muscular dystrophy (104)
Earnings (62628)
Editorial (47)
Employer branding (21)
Employer resources (153)
Events (107602)
Executive appointments (709)
FDA (16612)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (796)
Gene editing (123)
Generative AI (24)
Gene therapy (363)
GLP-1 (770)
Government (4449)
Grass and pollen (5)
Guidances (137)
Healthcare (18465)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (142)
Indications (30)
Infectious disease (2773)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (98)
Interviews (601)
IPO (14720)
IRA (45)
Job creations (2803)
Job search strategy (2136)
Kidney cancer (10)
Labor market (41)
Layoffs (457)
Leadership (23)
Legal (6123)
Liver cancer (73)
Lung cancer (331)
Lymphoma (157)
Machine learning (9)
Management (62)
Manufacturing (336)
MASH (77)
Medical device (11923)
Medtech (11926)
Mergers & acquisitions (16284)
Metabolic disorders (746)
Multiple sclerosis (82)
NASH (21)
Neurodegenerative disease (105)
Neuropsychiatric disorders (33)
Neuroscience (2034)
NextGen: Class of 2025 (6380)
Non-profit (4504)
Now hiring (32)
Obesity (396)
Opinion (262)
Ovarian cancer (81)
Pain (103)
Pancreatic cancer (81)
Parkinson's disease (157)
Partnered (20)
Patents (239)
Patient recruitment (115)
Peanut (49)
People (49998)
Pharmaceutical (78)
Pharmacy benefit managers (21)
Phase I (20401)
Phase II (28693)
Phase III (21280)
Pipeline (1347)
Policy (164)
Postmarket research (2360)
Preclinical (8773)
Press Release (68)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (266)
Rare diseases (428)
Real estate (5129)
Recruiting (70)
Regulatory (20821)
Reports (37)
Research institute (2528)
Resumes & cover letters (497)
Rett syndrome (5)
RNA editing (5)
RSV (39)
Schizophrenia (79)
Series A (136)
Series B (90)
Service/supplier (9)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3327)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (43)
The Weekly (67)
Vaccines (698)
Venture capitalists (44)
Weight loss (270)
Women's health (33)
Worklife (20)
Date
Today (112)
Last 7 days (924)
Last 30 days (3008)
Last 365 days (32480)
2025 (11699)
2024 (35014)
2023 (39220)
2022 (49532)
2021 (53890)
2020 (51712)
2019 (44648)
2018 (33782)
2017 (31225)
2016 (30771)
2015 (35416)
2014 (27655)
2013 (22739)
2012 (24008)
2011 (24486)
2010 (22312)
Location
Africa (877)
Alabama (56)
Alaska (7)
Arizona (174)
Arkansas (14)
Asia (37709)
Australia (6753)
California (6217)
Canada (1996)
China (547)
Colorado (265)
Connecticut (274)
Delaware (153)
Europe (87366)
Florida (910)
Georgia (203)
Idaho (52)
Illinois (547)
India (26)
Indiana (285)
Iowa (10)
Japan (166)
Kansas (104)
Kentucky (26)
Louisiana (12)
Maine (49)
Maryland (878)
Massachusetts (4844)
Michigan (214)
Minnesota (378)
Mississippi (1)
Missouri (79)
Montana (28)
Nebraska (21)
Nevada (57)
New Hampshire (61)
New Jersey (1749)
New Mexico (30)
New York (1782)
North Carolina (1020)
North Dakota (8)
Northern California (2722)
Ohio (204)
Oklahoma (15)
Oregon (34)
Pennsylvania (1389)
Puerto Rico (11)
Rhode Island (32)
South America (1163)
South Carolina (23)
Southern California (2335)
Tennessee (83)
Texas (901)
United States (23462)
Utah (168)
Virginia (151)
Washington D.C. (65)
Washington State (576)
West Virginia (3)
Wisconsin (52)
639,004 Results for "the james hutton institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.
May 1, 2024
·
1 min read
Press Releases
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 3, 2025
·
2 min read
Biotech Beach
ChemDiv to Participate in the EF Hutton Annual Global Conference, May 15, 2024
ChemDiv, Inc, announced that Bill Farley, CEO, will participate in the EF Hutton Annual Global Conference.
May 13, 2024
·
1 min read
Press Releases
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
February 24, 2025
·
1 min read
Press Releases
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
February 24, 2025
·
1 min read
Pharm Country
Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
Sonnet BioTherapeutics Holdings, Inc., a biopharmaceutical company developing innovative targeted biologic drugs, will be participating in the EF Hutton Annual Global Conference, which will take place on May 15, 2024 at The Plaza Hotel in New York.
May 6, 2024
·
2 min read
BioCapital
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
Processa Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announced that management will be participating in the EF Hutton Annual Global Conference being held May 15, 2024 at The Plaza Hotel in New York City.
May 6, 2024
·
2 min read
Press Releases
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
February 18, 2025
·
1 min read
Press Releases
ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference
February 14, 2025
·
1 min read
Pharm Country
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will participate in the EF Hutton Annual Global Conference, which will take place on May 15, 2024, at The Plaza Hotel in New York City.
May 8, 2024
·
2 min read
1 of 63,901
Next
